Penumbra, Inc. (NYSE:PEN) Shares Acquired by GAMMA Investing LLC

GAMMA Investing LLC increased its position in shares of Penumbra, Inc. (NYSE:PEN) by 160.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 446 shares of the company’s stock after purchasing an additional 275 shares during the quarter. GAMMA Investing LLC’s holdings in Penumbra were worth $106,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. True Wealth Design LLC bought a new position in Penumbra during the third quarter worth $26,000. Park Place Capital Corp lifted its stake in Penumbra by 1,473.9% during the third quarter. Park Place Capital Corp now owns 362 shares of the company’s stock worth $70,000 after purchasing an additional 339 shares during the last quarter. Northwestern Mutual Wealth Management Co. lifted its stake in Penumbra by 1,845.0% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 389 shares of the company’s stock worth $70,000 after purchasing an additional 369 shares during the last quarter. Advisors Asset Management Inc. lifted its stake in Penumbra by 11.5% during the third quarter. Advisors Asset Management Inc. now owns 416 shares of the company’s stock worth $81,000 after purchasing an additional 43 shares during the last quarter. Finally, Blue Trust Inc. lifted its stake in Penumbra by 808.9% during the third quarter. Blue Trust Inc. now owns 509 shares of the company’s stock worth $92,000 after purchasing an additional 453 shares during the last quarter. 88.88% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

PEN has been the topic of several research analyst reports. Citigroup raised their price objective on Penumbra from $220.00 to $245.00 and gave the stock a “neutral” rating in a research note on Wednesday, December 11th. Stifel Nicolaus assumed coverage on Penumbra in a research note on Tuesday, September 17th. They issued a “buy” rating and a $238.00 target price on the stock. Royal Bank of Canada raised their target price on Penumbra from $205.00 to $222.00 and gave the company an “outperform” rating in a research note on Tuesday, October 8th. Robert W. Baird raised their target price on Penumbra from $244.00 to $248.00 and gave the company an “outperform” rating in a research note on Thursday, October 31st. Finally, Wells Fargo & Company upgraded Penumbra from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $190.00 to $275.00 in a research note on Wednesday, December 11th. Four investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $258.00.

Insider Buying and Selling

In related news, EVP Johanna Roberts sold 600 shares of Penumbra stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $244.49, for a total transaction of $146,694.00. Following the transaction, the executive vice president now directly owns 63,444 shares of the company’s stock, valued at $15,511,423.56. The trade was a 0.94 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Harpreet Grewal sold 167 shares of Penumbra stock in a transaction dated Friday, January 3rd. The stock was sold at an average price of $241.28, for a total value of $40,293.76. Following the transaction, the director now directly owns 8,530 shares in the company, valued at approximately $2,058,118.40. The trade was a 1.92 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 48,819 shares of company stock valued at $11,197,883 over the last three months. Company insiders own 5.00% of the company’s stock.

Penumbra Price Performance

Shares of NYSE PEN opened at $250.36 on Friday. Penumbra, Inc. has a fifty-two week low of $148.00 and a fifty-two week high of $277.34. The firm’s 50-day simple moving average is $242.08 and its 200 day simple moving average is $209.63. The company has a quick ratio of 3.25, a current ratio of 5.82 and a debt-to-equity ratio of 0.02. The stock has a market cap of $9.61 billion, a P/E ratio of 291.12, a P/E/G ratio of 2.47 and a beta of 0.52.

Penumbra (NYSE:PEN) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $0.85 earnings per share for the quarter, beating analysts’ consensus estimates of $0.69 by $0.16. The business had revenue of $301.04 million for the quarter, compared to analysts’ expectations of $297.36 million. Penumbra had a net margin of 2.97% and a return on equity of 8.99%. The company’s revenue was up 11.1% on a year-over-year basis. During the same period in the previous year, the business earned $0.67 earnings per share. Equities analysts expect that Penumbra, Inc. will post 2.81 EPS for the current year.

About Penumbra

Penumbra, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.